Medical Marijuana Could Bring Nuvilex and the National Football League Together

NEW YORK, NY--(Marketwired - Feb 5, 2014) - Nuvilex, Inc. (OTCQB: NVLX) entered the medical marijuana arena in 2013 as a biotech that would use its expertise to develop treatments for hard to treat cancers. The company said it will initially utilize cannabidiol, one of the compounds found in Cannabis, as the basis for developing treatments for some of the deadliest forms of cancer, namely pancreatic cancer and cancers of the brain, that have historically shown they're extremely difficult to treat.

In the process of developing treatments for cancers of the brain, the company could find itself as the leader in researching the benefits of medicinal marijuana on concussions. With the Super Bowl just on the big stage, the marijuana debate landed on the doorstep of the National Football League (NFL). When asked, the league's commissioner, Roger Goodell said the NFL would consider allowing athletes to use marijuana to treat concussions and other head injuries if medical experts deemed it a legitimate solution.

Pete Carroll, the head coach of the Super Bowl Champion Seattle Seahawks, agrees with the commissioner. Carroll said he is in support of the NFL looking further into whether medicinal marijuana could be beneficial to players. In an ESPN SportsNation Poll answered by more than 66,000 people, 70 percent of those respondents said they too were okay with the NFL approving the use of medicinal marijuana.

When it comes to both cancer and diabetes, Nuvilex has exclusive worldwide rights to use Cell-in-a-Box™, a live-cell encapsulation technology that targets cancerous tumors, potentially inhibits progression, and treats the tumor at its core. So, while conducting research and developing treatments using Cannabis, Nuvilex and the NFL could find some common ground.

Nuvilex is one of the legitimate businesses in the marijuana industry waiting for regulations and nationwide legalization to play itself out in order to remove any legality that may face any company using the drug for medicinal purposes.

About Stock Market Media Group

SMMG is a full service IR firm specializing in Research and Content Development. It offers a platform for corporate stories to unfold through the media with Reports, Interviews and Articles. For more information and to read disclaimers and disclosures: www.stockmarketmediagroup.com.